GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Cash Conversion Cycle

Awakn Life Sciences (Awakn Life Sciences) Cash Conversion Cycle : 658.30 (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Awakn Life Sciences's Days Sales Outstanding for the three months ended in Oct. 2023 was 658.3.
Awakn Life Sciences's Days Inventory for the three months ended in Oct. 2023 was 0.
Awakn Life Sciences's Days Payable for the three months ended in Oct. 2023 was 0.
Therefore, Awakn Life Sciences's Cash Conversion Cycle (CCC) for the three months ended in Oct. 2023 was 658.30.


Awakn Life Sciences Cash Conversion Cycle Historical Data

The historical data trend for Awakn Life Sciences's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Cash Conversion Cycle Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23
Cash Conversion Cycle
- 44.89 9.17

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 2.74 12.64 528.29 658.30

Competitive Comparison of Awakn Life Sciences's Cash Conversion Cycle

For the Biotechnology subindustry, Awakn Life Sciences's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Cash Conversion Cycle Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Cash Conversion Cycle falls into.



Awakn Life Sciences Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Awakn Life Sciences's Cash Conversion Cycle for the fiscal year that ended in Jan. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=9.17+0-0
=9.17

Awakn Life Sciences's Cash Conversion Cycle for the quarter that ended in Oct. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=658.3+0-0
=658.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences  (OTCPK:AWKNF) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Awakn Life Sciences Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines